Strategic alliances in biotechnology and pharmaceuticals

Bibliographic Information

Strategic alliances in biotechnology and pharmaceuticals

Hans Gottinger, Celia Umali, and Frank Floether

(Biotechnology in agriculture, industry and medicine)

Nova Science, c2010

  • : hardcover

Available at  / 2 libraries

Search this Book/Journal

Note

Includes bibliographical references and index

Description and Table of Contents

Description

This book covers a strategic industry analysis of a globally operating pharmaceutical and biotechnology industry. Both biotechnology and large pharmaceutical firms compete in a network industry characterised by rapid technological change which leads to industry change and market structure. In particular, these firms depend on the creation of new knowledge. New knowledge presents particular issues regarding transferability. Innovation potentials and alliance competencies should be prevalent in any market characterised by fast changing intangible assets , given the difficulties in trading intangibles; moreover, in industries with very high rates of technology change, technologies can be introduced that create new market segments, obsolesce existing product lines, and create substantial competitors from previously little-known firms.

Table of Contents

  • Essentials for Alliance Formation
  • The Science & Technology Base of the Biotech Industry
  • Alliances in the Biotech Industry: An Industry Study of Network Economies
  • Alliance Propensity of Biotech-Pharma Companies: An Empirical Perspective
  • European Biotech-Pharma Industry Development
  • Emerging Asian Biotech-Pharma Industry -- Analysis & Trends
  • Emerging Asian Biotech-Pharma Industry -- Comparative Perspectives
  • Strategic Alliances: Post-Analysis & Projection
  • Index.

by "Nielsen BookData"

Related Books: 1-1 of 1

Details

Page Top